..it says they believe RLF-100 works and is worth investing millions of dollars.. RLFTF gets their cut.. IMO
..from tcm55 : The 'Jewel' is still RLF-100. Dispite the retorect from NRX the partnership is Relief 80-20% throughout the WORLD and 50-50% US/I/Ca for commercialization of RLF-100.
New Swiss and Turkey Inhaler Trials for Aviptadil by RLF are super significant, IMO.
The NeuroRX merger keeps moving forward which is good if u want to get rewarded for RLF-100 as an investor through BRPA. Otherwise u have to wait to get truly paid for RLF-100 through rlftf although getting fda and eau approval pats both entities equally from a profit standpoint, rlftf will lag because their such unethical lazy Europeans and decided they start their studies sometime in the 2028. Also, they care zero about their shareholders. It is criminal. I want to get paid for finding this investment last year and Brpa will be the way to get paid first and the rlftf down the road since the patent is theirs when the lazy Europeans get off their ass
News 
Market Data 
Discover 
